Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Evaluation Of Cone And Seed Quality Of Siberian Stone Pine (Pinus Sibirica Du Tour) For Plus-Tree Selection, Svetlana Velisevich, Alexander Popov
Evaluation Of Cone And Seed Quality Of Siberian Stone Pine (Pinus Sibirica Du Tour) For Plus-Tree Selection, Svetlana Velisevich, Alexander Popov
Turkish Journal of Agriculture and Forestry
Siberian stone pine (Pinus sibirica Du Tour) is a cone-bearing species with outstanding nutritious seeds, health-supporting properties, and nut oil. Currently, the main volume of pine nuts is harvested in natural forests, which causes damage to ecosystems. The best solution to this problem would be harvesting nuts on special pine nut plantations established on the basis of high-seeding clones. However, it is hampered by the low efficiency of the existing methods for assessing plus-tree productivity. This work focused on cone analysis in two sites used for plus-tree selection: a 42-year-old sparse forest plantation and a 186-224-year-old closed natural forest. The …
Study On Post Approval Source Change Of Active Pharmaceutical Ingredient In The Finished Product And Its Regulatory Requirements In Eu And Us, Kalpana Kamnoore, M. P. Venkatesh, T.M. Pramod Kumar
Study On Post Approval Source Change Of Active Pharmaceutical Ingredient In The Finished Product And Its Regulatory Requirements In Eu And Us, Kalpana Kamnoore, M. P. Venkatesh, T.M. Pramod Kumar
The Thai Journal of Pharmaceutical Sciences
Post approval changes are changes to any characteristic of pharmaceutical product after approval. Certificate of suitability of European pharmacopoeia (CEP) and drug master file (DMF) are two mechanisms for active pharmaceutical ingredient (API) registration. Regulatory requirements vary for each mechanism. This study focused on regulatory requirements for post approval API source change in the European Union (EU) and USA; and to delve on the mechanism of post approval API source changes in the USA and EU. To improve quality of the API, the most of the pharmaceutical industries concentrate on CEP certified source instead of DMF as CEP assures compliance …